TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis

American Journal of Pathology

Volumn 159, Issue 5, 2001, Pages 1689-1699

  Pettit, Allison R ^a   Ji, Hong ^b   Von Stechow, Dietrich ^b   Müller, Ralph ^b,c   Goldring, Steven R ^a   Choi, Yongwon ^d   Benoist, Christophe ^b   Gravallese, Ellen M ^a  

^a HARVARD INSTITUTES OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOCLAST DIFFERENTIATION FACTOR;

ALBERS SCHOENBERG DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE EROSION; CARTILAGE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; HISTOPATHOLOGY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; OSTEOCLAST; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; T LYMPHOCYTE ACTIVATION;

EID: 0035153246     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63016-7     Document Type: Article

References (50)

1. The erosive front: A topographic study of the junction between the pannus and the subchondral plate in the macerated rheumatoid metacarpal head
2. Chondroclasts and osteoclasts at subchondral sites of erosion in the rheumatoid joint
3. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor
4. Cysteine proteinase cathepsin K mRNA is expressed in synovium of patients with rheumatoid arthritis and is detected at sites of synovial bone destruction
5. Generation of osteoclastic function in mouse bone marrow cultures: Multinuclearity and tartrate-resistant acid phosphatase are unreliable markers for osteoclastic differentiation
6. Sequential expression of phenotype markers for osteoclasts during differentiation of precursors for multinucleated cells formed in long term human marrow cultures
7. Osteoclast markers accumulate on cells developing from human peripheral blood mononuclear precursors
8. Modulation of osteoclast differentiation
9. Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis
10. Calcitonin receptors as markers for osteoclastic differentiation: Correlation between generation of boneresorptive cells and cells that express calcitonin receptors in mouse bone marrow cultures
11. Expression of the calcitonin receptor in bone marrow cell cultures and in bone: A specific marker of the differentiated osteoclast that is regulated by calcitonin
12. Osteoclast-like cells in murine collagen induced arthritis
13. Induction of abundant osteoclast-like multinucleated giant cells in adjuvant arthritic rats with accompanying disordered high bone turnover
14. Expression of osteoclast differentiation factor at sites of bone erosion in collagen-induced arthritis
15. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
16. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
17. TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor
18. A homologue of the TNF receptor and its ligand enhance T- cell growth and dendritic-cell function
19. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption
20. Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines Biochem Biophys
21. Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells
22. A novel molecular mechanism modulating osteoclast differentiation and function
23. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density
24. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro
25. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis
26. Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyteexpressed TRANCE transgene
27. Regulation of peripheral lymph node genesis by the tumor necrosis factor family member TRANCE
28. TRANCE, a tumor necrosis factor family member, enhances the longevity and adjuvant properties of dendritic cells in vivo
29. Involvement of receptor activator of nuclear factor kappa-B ligand/osteoclast differentiation factor in osteocclastogenesis from synoviocytes in rheumatoid arthritis
30. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand
31. Activated T lymphocytes support osteoclast formation in vitro
32. Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme
33. From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins
34. Organ-specific disease provoked by systemic autoimmunity
35. A microtomographic system for the nondestructive evaluation of bone architecture
36. Morphometric analysis of human bone biopsies: A quantitative structural comparison of histological sections and micro-computed tomography
37. Quantification of periapical bone destruction in mice by micro-computed tomography
38. Micro-tomographic imaging for the nondestructive evaluation of trabecular bone architecture
39. Non-invasive bone biopsy: A new method to analyze and display the three-dimensional structure of trabecular bone
40. A role for osteocalcin in osteoclast differentiation
41. Sennello G, Frazier J, Chlipala E, McCabe D: Efficacy of sustained blood levels of interleukin-1 receptor antagonist in animal models of arthritis: Comparison of efficacy in animal models with human clinical data
42. Genetic influences on the end-stage effector phase of arthritis
43. Failure of cells of the mononuclear phagocyte series to resorb bone
44. Gene expression during osteoclast-like cell formation induced by antifusion regulatory protein- 1/CD98/4F2 monoclonal antibodies (MAbs): c-src is selectively induced by anti-FRP-1 MAb
45. Initiation of osteoclast bone resorption by interstitial collagenase
46. Expression of proteinases and inflammatory cytokines in subchondral bone regions in the destructive joint of rheumatoid arthritis
47. Fibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis
48. NE-58095: A diphosphonate which prevents bone erosion and preserves joint architecture in experimental arthritis
49. Increased bone mass with pamidronate treatment in rheumatoid arthritis; results of a three-year randomized double-blind trial
50. Intranasal calcitonin for the prevention of bone erosion and bone loss in rheumatoid arthritis